tiprankstipranks
Trending News
More News >
Axsome Therapeutics Inc (AXSM)
NASDAQ:AXSM
US Market

Axsome Therapeutics (AXSM) Income Statement

Compare
2,286 Followers

Axsome Therapeutics Income Statement

Last quarter (Q3 2025), Axsome Therapeutics's total revenue was $170.99M, an increase of 63.22% from the same quarter last year. In Q3, Axsome Therapeutics's net income was $-47.23M. See Axsome Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 385.69M$ 270.60M$ 50.04M$ 0.00$ 0.00
Gross Profit
$ 352.39M$ 244.53M$ 44.84M$ 0.00$ 0.00
Operating Expenses
$ 632.95M$ 476.36M$ 224.64M$ 124.71M$ 99.14M
Depreciation and Amortization
$ 7.96M$ 6.83M$ 4.40M$ 76.00K$ 77.72K
EBITDA
$ -272.60M$ -224.99M$ -175.40M$ -124.63M$ -100.31M
Operating Income
$ -280.56M$ -231.82M$ -179.80M$ -124.71M$ -99.14M
Other Income/Expenses
$ -6.57M$ -6.45M$ -7.33M$ -5.70M$ -3.76M
Pretax Income
$ -287.13M$ -238.28M$ -187.13M$ -130.40M$ -102.90M
Net Income
$ -287.22M$ -239.24M$ -187.13M$ -130.40M$ -102.90M
Per Share Metrics
Basic EPS
$ -5.99$ -5.27$ -4.60$ -3.47$ -2.83
Diluted EPS
$ -5.99$ -5.27$ -4.60$ -3.47$ -2.83
Weighted Average Shares Outstanding
47.91M 45.43M 40.66M 37.62M 37.21M
Weighted Average Shares Outstanding (Diluted)
47.91M 45.43M 40.66M 37.62M 37.21M
Currency in USD

Axsome Therapeutics Earnings and Revenue History